KP Tissue (KPT) Gets a Buy Rating from Scotiabank


Shares of KP Tissue (KPT) were revisited by a Wall Street analyst on January 3. Analyst Benoit Laprade from Scotiabank remains bullish on the stock and has a C$9.75 price target.

According to TipRanks.com, Laprade is a 2-star analyst with an average return of -0.4% and a 57.4% success rate. Laprade covers the Basic Materials sector, focusing on stocks such as West Fraser Timber Co Ltd, Louisiana-Pacific, and Cascades Inc.

Read also: Nike (NKE) Earnings: Bulls Win, What’s Next?

Currently, the analyst consensus on KP Tissue is a Moderate Buy with an average price target of C$9.19.

Based on KP Tissue’s latest earnings release for the quarter ending September 30, the company reported a quarterly GAAP net loss of C$832K. In comparison, last year the company had a GAAP net loss of C$4.22 million.

KP Tissue, Inc. operates as a holding company engages in the production, distribution, marketing, and sale of products, including bathroom tissue, facial tissue, paper towels and napkins, for both the consumer and the away-from-home market. It operates through the following segments: Away-From-Home, Consumer, and Other. The Away-From-Home includes the Purex, Esteem, White Swan, Embassy, and Chalet brands. The Consumer segment operates through the following brands: Cashmere, Purex, Scotties, SpongeTowels, and White Cloud. The Other segment consists primarily of parent rolls sold to third parties in Canada and the United States through brokers. The company was founded in October 2012 and is headquartered in Mississauga, Canada.

The company’s shares closed on Friday at C$8.26.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts